Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
The FDA approval process for both peptides is ongoing
immune function effects in animal models Regulatory status (as of publication): Not approved by the FDA, EMA, or any other Western regulatory authority for any indication
The molecular basis for this selectivity difference is not fully characterized at the structural level but is attributed to ipamorelin's distinct binding mode at the receptor's orthosteric site, which appears to bias the downstream signaling cascade toward the GH-releasing pathway rather than the full spectrum of ghrelin receptor activity
Its use is investigational, and it is not approved by any regulatory authority for the treatment of any specific medical condition
The combination of B12 for energy and MIC for fat metabolism provides a practical boost that many patients find motivating and helpful
US$ 24.39
US$ 23.92
US$ 28.49
US$ 22.61
